Forty Seven Aktie - FTSV

Rendering Error

Professionelle Tools für Privatanleger.

Premium

Current Price

95,51

Gebot

95,51

Fragen

95,49

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

95,51

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights

-- Presented Updated Data for Magrolimab Showing Robust, Durable Activity in MDS and AML Presented Foundational...

Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia

MENLO PARK, Calif. and NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV) and...

Moore Kuehn Encourages FTSV, MINI, POPE, WAAS, and TLRA Investors to Contact Law Firm

Moore Kuehn Encourages FTSV, MINI, POPE, WAAS, and TLRA Investors to Contact Law Firm PR Newswire NEW YORK...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc. PR Newswire NEW YORK, March 3, 2020 NEW YORK...

(FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal?

(FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal? PR Newswire SAN DIEGO, March...

Gilead to Acquire Forty Seven for $4.9 Billion

– Gilead Gains Forty Seven’s Investigational Immuno-Oncology Therapy in Multiple Clinical Studies for Diseases Including Myelodysplastic...

Forty Seven to Present at Upcoming Investor Conferences in March

MENLO PARK, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq:FTSV), a clinical-stage...

Forty Seven to Present at Upcoming Investor Conferences in February

MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq:FTSV), a clinical-stage...

Forty Seven Announces 2020 Strategic Priorities and Expected Milestones

-- Registration-Enabling Programs in MDS and DLBCL On-Track; Initiation of Phase 3 ENHANCE Trial in MDS and...

Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Sha...

MENLO PARK, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV), a clinical stage...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

FTSV - Frequently Asked Questions (FAQ)

What is the current Forty Seven share price?

The current share price of Forty Seven is US$ 95,51

What is the 1 year trading range for Forty Seven share price?

Forty Seven has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
PRTGPortage Biotech Inc	US$ 9,60 (103,82%)	29,92M
LXRXLexicon Pharmaceuticals Inc	US$ 0,5741 (65,16%)	405,3M
DBVTDBV Technologies SA	US$ 6,12 (56,52%)	21,8M
MYSZMy Size Inc	US$ 1,79 (42,06%)	11,89M
LXEHLixiang Education Holding Company Ltd	US$ 17,70 (32,78%)	217,53k
STSSSharps Technology Inc	US$ 0,0421 (-72,43%)	214,43M
MISTMilestone Pharmaceuticals Inc	US$ 0,88 (-60,89%)	33,47M
XTIAXTI Aerospace Inc	US$ 1,23 (-50,00%)	1,82M
LGMKLogicMark Inc	US$ 0,0258 (-49,41%)	161,36M
ICONIcon Energy Corporation	US$ 0,0516 (-48,40%)	27,6M
LXRXLexicon Pharmaceuticals Inc	US$ 0,5741 (65,16%)	405,3M
DMNDamon Inc	US$ 0,0346 (-22,42%)	314,35M
NVDANVIDIA Corporation	US$ 109,67 (-1,58%)	229,88M
STSSSharps Technology Inc	US$ 0,0421 (-72,43%)	214,43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9,845 (-7,30%)	200,21M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Forty Seven Inc (FTSV)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

FTSV Neueste Nachrichten

Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights

Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia

Moore Kuehn Encourages FTSV, MINI, POPE, WAAS, and TLRA Investors to Contact Law Firm

SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc.

(FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal?

Gilead to Acquire Forty Seven for $4.9 Billion

Forty Seven to Present at Upcoming Investor Conferences in March

Forty Seven to Present at Upcoming Investor Conferences in February

Forty Seven Announces 2020 Strategic Priorities and Expected Milestones

Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Sha...

FTSV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Forty Seven Inc (FTSV) Börsenkurse

Forty Seven Inc (FTSV)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

FTSV Neueste Nachrichten

Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights

Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia

Moore Kuehn Encourages FTSV, MINI, POPE, WAAS, and TLRA Investors to Contact Law Firm

SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc.

(FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal?

Gilead to Acquire Forty Seven for $4.9 Billion

Forty Seven to Present at Upcoming Investor Conferences in March

Forty Seven to Present at Upcoming Investor Conferences in February

Forty Seven Announces 2020 Strategic Priorities and Expected Milestones

Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Sha...

FTSV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS